FDA approves another generic abortion pill, prompting outrage from conservatives

By

The Associated Press

The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, D.C., on April 22, 2025.

WASHINGTON — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration.

Drugmaker Evita Solutions announced on its website that the Food and Drug Administration signed off on its low-cost form of the pill, which is approved to end pregnancies through 10 weeks.